6
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Relation of plasma glycine, serine, and homocysteine levels to schizophrenia symptoms and medication type.

      The American Journal of Psychiatry

      Adult, Amino Acids, blood, physiology, Antipsychotic Agents, therapeutic use, Clozapine, Female, Glycine, Homocysteine, Humans, Male, Middle Aged, Psychiatric Status Rating Scales, Receptors, N-Methyl-D-Aspartate, Schizophrenia, diagnosis, physiopathology, Schizophrenic Psychology, Serine

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Altered glycine and homocysteine levels may contribute to N-methyl-D-aspartate receptor dysfunction in schizophrenia. The authors measured plasma levels of these amino acids in a group of patients with chronic schizophrenia and related them to the patients' symptom profiles and types of antipsychotic medication. Plasma levels of amino acids in 94 patients with schizophrenia were compared with those in 34 age- and sex-matched normal subjects. The Positive and Negative Syndrome Scale was used to evaluate the patients' psychopathology. Plasma glycine levels and glycine-serine ratios were lower and homocysteine levels were higher in patients than in comparison subjects. Low glycine levels correlated with a greater number of negative symptoms. The glycine-serine ratios of normal subjects and patients being treated with clozapine did not differ significantly. These findings support the hypothesis that altered levels of glycine and homocysteine may coexist in patients with schizophrenia and contribute to pathophysiological aspects of this illness.

          Related collections

          Author and article information

          Journal
          16135636
          10.1176/appi.ajp.162.9.1738

          Comments

          Comment on this article